Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Physicians in the Smidt Heart Institute at Cedars-Sinai have pioneered using a catheter-based approach to treat patients with tricuspid valve disease. Image by Getty.

News | Structural Heart

Smidt Heart Institute Physicians Advance Transcatheter Tricuspid Valve Replacement

February 9, 2024 — Physicians in the Smidt Heart Institute at Cedars-Sinai have achieved two significant firsts ...

February 09, 2024

ResearcherLate-breaking science from the American Stroke Association’s International Stroke Conference, ISC 2024, reports researchers found an artificial intelligence (AI) system to help guide treatment decisions for stroke patients led to improved stroke care quality and fewer recurrent strokes, heart attacks and vascular death among stroke survivors three months after a stroke.

News | AHA

International Stroke Conference Researcher Finds AI-based System Helped Guide Treatment, Lowered Stroke Recurrence

February 8, 2024 — The latest late-breaking science from the second day of the American Stroke Association’s Internation ...

February 08, 2024

This new document builds off of the previously published Best Practices for Consumer Cardiovascular Technology Solutions in January 2022.

News | ACC

CTA and ACC Collaborate to Tackle Cardiovascular Disease with Technology

February 7, 2024 — The Consumer Technology Association (CTA) and the American College of Cardiology (ACC) are announcing ...

February 07, 2024

New phenomapping tool and clinical score could lead to personalized strategies for patients hospitalized with ADHF

News | Artificial Intelligence

Machine Learning Informs a New Tool to Guide Treatment for Acute Decompensated Heart Failure

February 6, 2024 — A recent study co-authored by Dr. Matthew Segar, a third-year cardiovascular disease fellow at The ...

February 06, 2024

ATTRibute-CM results also demonstrated rapid clinical benefit on the composite endpoint of all-cause mortality (ACM) and CVH in patients treated with acoramidis, with time-to-first event Kaplan-Meier curves separating at month 3 and continuing to diverge steadily through Month 30

News | FDA

BridgeBio Pharma Announces U.S. Food and Drug Administration (FDA) Acceptance of New Drug Application (NDA) for Acoramidis for the Treatment of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

February 6, 2024 — BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company focused on genetic diseases and ...

February 06, 2024

The EVOQUE system is indicated for the improvement of health status in patients with symptomatic severe TR despite optimal medical therapy (OMT), for whom tricuspid valve replacement is deemed appropriate by a heart team.

News | FDA

Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy Earns FDA Approval for Tricuspid Valve

February 2, 2024 — Edwards Lifesciences Corporation announced the company’s EVOQUE tricuspid valve replacement system is ...

February 02, 2024

In addressing efficacy, harm, and logistics, the study passes all three of the criteria suggested by the American Heart Association guiding the implementation of polygenic risk scores (PRSs) in cardiovascular care

News | Cardiovascular Clinical Studies

Genomics plc Publishes Clinical Trial Results Demonstrating Successful Integration and Clinical Utility of Integrated Risk Scores Combining Polygenic and Clinical Risk of Cardiovascular Disease in NHS Primary Care

February 1, 2024 — Genomics plc (Genomics), a healthcare company aiming to transform health through the power of ...

February 01, 2024

As cardiologists, heart disease patients and the organizations that serve them across the country embark on American Heart Month, ITN has compiled a snapshot of significant cardiovascular disease (CVD) and stroke statistics, along with a review of the atherosclerosis drug market.

Feature | Cardiovascular Education | Christine Book

American Heart Month Puts Spotlight on Cardiovascular Disease and Stroke Statistics

February 1, 2024 — As cardiologists, heart disease patients and the organizations that serve them across the country ...

February 01, 2024

Here is a look at the most-read content during the month of January on dicardiology.com

Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Top 10: What Viewers Were Reading in January

It is a new year with lots of new content! Here is a look at the most-read content during the month of January on dicard ...

February 01, 2024

News | FDA

W. L. Gore Receives FDA Approval for Lower Profile Gore Viabahn VBX Balloon Expandable Endoprosthesis

January 31, 2024 — As part of efforts to continuously improve medical solutions for patients with complex vascular ...

January 31, 2024

Study Reveals Nuances in Pediatric Cardiac Surgery Quality Metrics

News | STS

New Research Finds Volume Alone Does Not Predict Quality Outcomes in Pediatric Cardiac Surgery

January 30, 2024 — A study of pediatric heart surgery centers across the United States has demonstrated that, when it ...

January 30, 2024

Universal risk predictor for cardiovascular disease, suitable for use in both primary and secondary prevention, would streamline risk assessment

News | Heart Failure

Johns Hopkins Bloomberg School Researchers Develop Universal Risk Predictor for Cardiovascular Disease

January 30, 2024 — Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single ...

January 30, 2024

News | Sudden Cardiac Arrest

Emergency Cardiovascular Care Impact Goal Outlines 3 Target Needs

January 30, 2024 — Only 10% of people who experience a cardiac arrest survive.[1] In new challenge goals outlined in the ...

January 30, 2024

A new study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas, examines the ongoing controversy surrounding the choice between multi-arterial grafting (MAG) and single arterial grafting (SAG) in coronary artery bypass grafting (CABG) for multivessel coronary revascularization

News | STS

New Research Highlights Superior Long-Term Survival with Multi-Arterial Coronary Artery Bypass Grafting Over Single Arterial Grafting

January 29, 2024 — A new study presented at The Society of Thoracic Surgeons’ 2024 Annual Meeting in San Antonio, Texas ...

January 29, 2024

Researchers uncover critical factors for improved patient safety in lung cancer resection– An analysis of the STS general thoracic surgery database

News | Pulmonary Embolism

Breakthrough Research Identifies Predictors of Venous Thromboembolism after Pulmonary Resection for Lung Cancer

January 29, 2024 — In patients who undergo pulmonary resection for lung cancer, a major potential postoperative ...

January 29, 2024